Under construction – not a live service
Sign in
Taking people in BelgiumNo phase

Cardiac RadiothErapy for VEntricular Tachycardia II

Key facts

Who runs it
Universitaire Ziekenhuizen KU Leuven
Where
Leuven, BelgiumSee the site
Trial code
Status
Recruiting
People taking part
50 people, planned
Started
1 Jan 2025
Expected to end
Dec 2034
Type of study
Observational
Treatments tested
  • stereotactic radiotherapy ablation
Record updated
29 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Eligible for STAR for therapy-refractory VT based on a multidisciplinary discussion
  • Ability to give a written informed consent and willingness to return for follow-up

Who cannot take part

  • Contra-indications for STAR, including pregnancy or breastfeeding, previous radiotherapy with cardiac involvement, life-expectancy < 6 months in the absence of VT
  • Any condition that is deemed a contraindication in the judgment of the investigators

Where in Belgium

  • UZ LeuvenLeuven, BelgiumContact: Bert Vandenberk, MD PhDTaking people

About the trial

What the trial wants to find out

Steoreotactic therapy radioablation has become a standard of care option for patients with therapy-refractory ventricular tachycardia, yet long-term outcome is lacking. The objective of this study is to evaluate the long-term outcomes, both efficacy and safety, after STAR in patients with therapy-refractory ventricular tachycardia.

Treatments tested

  • stereotactic radiotherapy ablation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Cardiac RadiothErapy for VEntricular Tachycardia II - a Prospective Observational Cohort Study
Record updated
29 April 2026